ArticleCrohn's & colitis 360Published
The Efficacy and Safety of Switching From Originator Infliximab to Single or Double Switch Biosimilar Among a Nationwide Cohort of Inflammatory Bowel Disease Patients
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Crohn's & colitis 360
- Published
- Topic
- Clinical care
- Subject terms
- Inflammatory Bowel Disease; Infliximab; Biosimilars; Double Switch; Inflectra; Renflexis; Single Switch
- PubMed ID
- 36778941
- PubMed Central ID
- PMC9802034
- Open access
- Yes, free to read
- Added to directory
- Source checked